1-155235007-C-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPP5_Moderate
The NM_000157.4(GBA1):c.1599G>A(p.Trp533Ter) variant causes a stop gained change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 11)
Consequence
GBA1
NM_000157.4 stop_gained
NM_000157.4 stop_gained
Scores
2
3
2
Clinical Significance
Conservation
PhyloP100: 3.97
Genes affected
GBA1 (HGNC:4177): (glucosylceramidase beta 1) This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 6 pathogenic variants in the truncated region.
PP5
Variant 1-155235007-C-T is Pathogenic according to our data. Variant chr1-155235007-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 917862.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GBA1 | NM_000157.4 | c.1599G>A | p.Trp533Ter | stop_gained | 11/11 | ENST00000368373.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GBA1 | ENST00000368373.8 | c.1599G>A | p.Trp533Ter | stop_gained | 11/11 | 1 | NM_000157.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 11
GnomAD3 genomes
Cov.:
11
GnomAD4 exome Cov.: 9
GnomAD4 exome
Cov.:
9
GnomAD4 genome Cov.: 11
GnomAD4 genome
Cov.:
11
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Gaucher disease type I Pathogenic:1
Pathogenic, no assertion criteria provided | research | Department of Pediatrics, Division of Medical Genetics, Faculty of Medicine Ramathibodi Hospital, Mahidol University | Jun 04, 2020 | The c.1599G>A variant in GBA was absent from large population and our in-house database. This variant segregated with the non-neuronopathic Gaucher disease. The glucocerbrosidase enzyme activity was deficient. - |
Gaucher disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 15, 2023 | Variant summary: GBA c.1599G>A (p.Trp533X) results in a premature termination codon. While the variant is not expected to undergo nonsense-mediated decay, variants downstream of this position have been classified as pathogenic by our laboratory (p.Arg535Cys, p.Arg535His). The variant was absent in 176860 control chromosomes. c.1599G>A has been reported in the literature in compound heterozygous indivudals affected with Gaucher Disease including one neonatal case who carried a VUS in cis and a pathogenic variant in trans (Phetthong_2021, Lecourt_2013). At least one publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Lecourt_2013). The following publications have been ascertained in the context of this evaluation (PMID: 23935976, 34930372). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Benign
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
D;D;D;D;D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at